By Dr. Chinta Sidharthan Apr 24 2024 Reviewed by Susha Cheriyedath, M.Sc. In a recent study published in the journal Proceedings of the National Academy of Sciences , a team of researchers from Yale University's School of Medicine and Harvard University used murine models to assess whether intranasally administered neomycin sulfate could evoke antiviral protection against respiratory viruses such as influenza A and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inducing the